However, before CRISPR-Cas9 technology may be of therapeutic use in C9orf72-linked ALS, it will be important to address the problem of potentially introducing insertion/deletion events into the wild-type allele, which may have functional consequences to the C9orf72 gene56. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.